In the latest Cancer Advances podcast, a veteran neurosurgeon profiles the enduring place of stereotactic radiosurgery in brain metastasis therapy and why most patients can be offered reassurance about prospects for metastasis control.
Outcomes correlate with the number of brain metastases primarily in patients without two actionable molecular targets: epidermal growth factor receptor mutations or anaplastic lymphoma kinase translocations.
The latest in our Neuro Pathways podcast series summarizes the heartening recent progress in surgical and medical treatment of this common malignancy.
Which research results from the American Society for Radiation Oncology’s 2019 annual meeting are the most interesting or clinically relevant? The staff of Cleveland Clinic Cancer Center’s Department of Radiation Oncology picks their Top 10.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
If findings continue to echo results to date, preoperative higher-dose stereotactic radiosurgery could represent a new standard of care for patients with large brain metastases.
More and more of our patients with brain metastases are undergoing stereotactic radiosurgery. Recent outcomes data show it’s paying off in terms of survival and functional performance.
The first case series outside Japan suggests this novel approach holds potential advantages over other radiosurgery strategies in survival, convenience and radiobiological effects.
Except for certain targeted agents, the answer is “yes,” a new study shows. But whole-brain radiation should be avoided as initial treatment for patients on systemic therapy.
This remarkable case of multiple metastases over eight years in a resilient young man culminates in one of the earliest U.S. uses of staged Gamma Knife® radiosurgery for brain metastases.
This 49-year-old breast cancer patient with brain metastases received the first reported combined use of laser ablation with endoscopically assisted debulking of an intracranial tumor.